Suppr超能文献

DLGAP5基因的致病性变异导致以卵母细胞成熟停滞和胚胎停滞为特征的女性不孕。

Pathogenic variants in DLGAP5 cause female infertility characterized by oocyte maturation arrest and embryonic arrest.

作者信息

Qu Ronggui, Liang Fan, Fan Li, Shi Rong, Chen Zhixian, Chen Biaobang, Gu Hao, Du Xingzhu, Wu Tianyu, Fan Huizhen, Yu Ran, Luo Yuxi, Mu Jian, Wang Weijie, Li Qiaoli, Shi Juanzi, Wang Lei, Sun Xiaoxi, Zhang Zhihua, Sang Qing

机构信息

Institute of Pediatrics, Children's Hospital of Fudan University, the Institutes of Biomedical Sciences, and the State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China.

Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.

出版信息

Hum Reprod. 2025 Jul 10. doi: 10.1093/humrep/deaf139.

Abstract

STUDY QUESTION

Can new genetic factors responsible for oocyte defects be identified in infertile women, especially for those with spindle assembly defects?

SUMMARY ANSWER

We identified homozygous and compound heterozygous variants of DLGAP5 in three infertile individuals from two independent families.

WHAT IS KNOWN ALREADY

Some genes have been found to be responsible for female infertility with oocyte maturation defects. During mitosis, DLGAP5 is involved in promoting microtubule polymerization and spindle formation.

STUDY DESIGN, SIZE, DURATION: The DLGAP5 variants were identified by whole-exome sequencing in a cohort of 3627 female infertility patients diagnosed with oocyte maturation defects or embryonic development problems, and all participants were recruited from 2015 to 2023. Thirty-six hours after cell transfection, the expression levels of wild-type (WT) and mutant DLGAP5 were evaluated by western blot (n = 3 biological replicates). Human germinal vesicle (GV) oocytes retrieved from assisted reproductive procedure were introduced for cRNA (n = 3-5 oocytes per group) and antibody injection (n = 10-15 oocytes per group). Knock-in (KI) mouse model was generated by CRISPR-Cas9 and genotyping was performed at postnatal Days 10-15. Sexually mature females (6-10 weeks old) were used for fertility test (n = 6 mice per group, lasts 6-8 months), western blot (n = 3 biological replicates), IVF (n = 3 biological replicates), embryos collection (n = 3 biological replicates), immunofluorescence (n = 3 biological replicates), RNA-sequencing (RNA-seq, n = 3 biological replicates), and other functional assays between 2019 and 2023.

PARTICIPANTS/MATERIALS, SETTING, METHODS: The DLGAP5 variants were identified by whole-exome sequencing and further confirmed by Sanger sequencing. Western blot was used to detect the expression of mutant DLGAP5 in HEK-293T cells after transfection. cRNA injection and immunofluorescence were performed to view the location of DLGAP5 in human oocytes. Knockdown of DLGAP5 by Trim-Away in human oocytes was conducted to observe the effect of DLGAP5 on spindle assembly and oocyte maturation. Then, Dlgap5 KI mice were constructed to mimic the phenotype of the affected individuals. After phenotypic assessment, western blot, IVF, assessment of embryonic development, chromosome counting, RNA-seq, and quantitative real-time PCR were performed to elucidate the pathological mechanism of DLGAP5 variants.

MAIN RESULTS AND THE ROLE OF CHANCE

We identified homozygous nonsense DLGAP5 variant (NM_014750.5, c.431delA (p.Lys144Argfs55)) in two affected sisters from family 1 and compound heterozygous variants (c.C847G (p.Pro283Ala) and c. C1202G (p.Thr401Ser)) in one infertile individual in family 2. p. Lys144Argfs55 led to protein degradation (P < 0.0001) and p. Pro283Ala resulted in a significant decrease in protein level (P = 0.0021). DLGAP5 was located on the spindle and mutant did not alter its location. Knockdown of DLGAP5 in human oocytes impaired spindle assembly and led to oocyte maturation arrest (P = 0.0055). Homozygous (HO) Dlgap5 KI female mice showed reduced fertility (P < 0.0001) due to embryonic arrest at the 4-cell stage (P < 0.0001) and a low blastocyst formation rate (P < 0.0001). RNA-seq data of 4-cell embryos showed that differentially expressed genes (DEGs) were involved in cell cycle regulation, checkpoint control, and TGF-β signaling pathways, which may account for the embryonic development arrest.

LARGE SCALE DATA

N/A.

LIMITATIONS, REASONS FOR CAUTION: Due to phenotypic differences between different DLGAP5 variants, more cases are needed to expand our understanding of the function of DLGAP5 in female infertility. Although RNA-seq data have shown the potential impact of DLGAP5 on cell cycle, embryonic development, and regulation of TGF-β signaling, more experiments are still requested to demonstrate the more direct role of DLGAP5 in oocyte and embryonic development.

WIDER IMPLICATIONS OF THE FINDINGS

Our findings elucidated the role of DLGAP5 in human oocyte spindle assembly and the effects of the corresponding variants in the pathogenesis of oocyte maturation arrest, and these findings suggest that DLGAP5 is a novel maker for genetic counseling.

STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Key Research and Development Program of China (2024YFC2706600), the National Natural Science Foundation of China (82325021, 82288102, 32130029, 82371662, 82171643, 82201767, 82422033), the National Key Research and Development Program of China (2022YFC2702300), the New Cornerstone Science Foundation through the XPLORER PRIZE, L.W. is a SANS Exploration Scholar, and the Fund of Fudan University and Cao'ejiang Basic Research (24FCB01). None of the authors declare any conflict of interest.

TRIAL REGISTRATION NUMBER

N/A.

摘要

研究问题

能否在不孕女性中,尤其是那些存在纺锤体组装缺陷的女性中,鉴定出导致卵母细胞缺陷的新遗传因素?

总结答案

我们在来自两个独立家庭的三名不孕个体中鉴定出了DLGAP5的纯合和复合杂合变异。

已知信息

已发现一些基因与伴有卵母细胞成熟缺陷的女性不孕有关。在有丝分裂过程中,DLGAP5参与促进微管聚合和纺锤体形成。

研究设计、规模、持续时间:通过全外显子组测序在一组3627名被诊断为卵母细胞成熟缺陷或胚胎发育问题的女性不孕患者中鉴定DLGAP5变异,所有参与者均在2015年至2023年期间招募。细胞转染36小时后,通过蛋白质免疫印迹法评估野生型(WT)和突变型DLGAP5的表达水平(n = 3个生物学重复)。从辅助生殖程序中获取的人类生发泡(GV)卵母细胞用于注射cRNA(每组n = 3 - 5个卵母细胞)和抗体(每组n = 10 - 15个卵母细胞)。通过CRISPR - Cas9构建敲入(KI)小鼠模型,并在出生后第10 - 15天进行基因分型。性成熟雌性小鼠(6 - 10周龄)用于生育力测试(每组n = 6只小鼠,持续6 - 8个月)、蛋白质免疫印迹法(n = 3个生物学重复)、体外受精(n = 3个生物学重复)、胚胎收集(n = 3个生物学重复)、免疫荧光(n = 3个生物学重复)、RNA测序(RNA - seq,n = 3个生物学重复)以及在2019年至2023年期间进行的其他功能测定。

参与者/材料、设置、方法:通过全外显子组测序鉴定DLGAP5变异,并通过桑格测序进一步确认。蛋白质免疫印迹法用于检测转染后HEK - 293T细胞中突变型DLGAP5的表达。进行cRNA注射和免疫荧光以观察DLGAP5在人类卵母细胞中的定位。通过Trim - Away在人类卵母细胞中敲低DLGAP5,以观察DLGAP5对纺锤体组装和卵母细胞成熟的影响。然后,构建Dlgap5 KI小鼠以模拟受影响个体的表型。在进行表型评估后,进行蛋白质免疫印迹法、体外受精、胚胎发育评估、染色体计数、RNA测序和定量实时PCR,以阐明DLGAP5变异的病理机制。

主要结果及偶然性的作用

我们在来自家族1的两名受影响姐妹中鉴定出纯合无义DLGAP5变异(NM_014750.5,c.431delA(p.Lys144Argfs55)),在家族2的一名不孕个体中鉴定出复合杂合变异(c.C847G(p.Pro283Ala)和c.C1202G(p.Thr401Ser))。p.Lys144Argfs55导致蛋白质降解(P < 0.0001),p.Pro283Ala导致蛋白质水平显著降低(P = 0.0021)。DLGAP5位于纺锤体上,突变体未改变其定位。在人类卵母细胞中敲低DLGAP5会损害纺锤体组装并导致卵母细胞成熟停滞(P = 0.0055)。纯合(HO)Dlgap5 KI雌性小鼠由于在4细胞阶段胚胎停滞(P < 0.0001)和低囊胚形成率(P < 0.0001)而生育力降低(P < 0.0001)。4细胞胚胎的RNA测序数据表明,差异表达基因(DEG)参与细胞周期调控、检查点控制和TGF - β信号通路,这可能解释胚胎发育停滞的原因。

大规模数据

无。

局限性、谨慎原因:由于不同DLGAP5变异之间存在表型差异,需要更多病例来扩展我们对DLGAP5在女性不孕中功能的理解。尽管RNA测序数据已显示DLGAP5对细胞周期、胚胎发育和TGF - β信号调控的潜在影响,但仍需要更多实验来证明DLGAP5在卵母细胞和胚胎发育中更直接的作用。

研究结果的更广泛意义

我们的研究结果阐明了DLGAP5在人类卵母细胞纺锤体组装中的作用以及相应变异在卵母细胞成熟停滞发病机制中的影响,这些结果表明DLGAP5是遗传咨询的一个新标志物。

研究资金/利益冲突:本研究得到中国国家重点研发计划(2024YFC2706600)、国家自然科学基金(82325021、82288102、32130029、82371662、82171643、82201767、82422033)、中国国家重点研发计划(2022YFC2702300)、新基石科学基金通过探索奖、L.W.是散思探索学者以及复旦大学和曹娥江基础研究基金(24FCB01)的支持。所有作者均未声明存在任何利益冲突。

试验注册号

无。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验